$80.0M
The financing round featured backing from investors including AstraZeneca, Hitachi Ventures, and Leaps by Bayer.
Huma Therapeutics
Huma Therapeutics builds digital health platforms for care and research.
$210MTotal raised
Healthcare technology company providing digital platforms for remote patient monitoring, companion applications, and clinical trials.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Huma Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
AM
Alan Milburn
Chairman of Huma’s Board
CS
Claudia Suessmuth Dyckerhoff
Huma Board Director
Investors
- $80.0M
- $130M
Funding history
$130M
The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.